echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > Innovent announced the results of a phase Ib clinical study of GLP-1R/GCGR dual agonist IBI362 in Chinese patients with type 2 diabetes at the International Diabetes Federation Conference (IDF 2021) in 2021

    Innovent announced the results of a phase Ib clinical study of GLP-1R/GCGR dual agonist IBI362 in Chinese patients with type 2 diabetes at the International Diabetes Federation Conference (IDF 2021) in 2021

    • Last Update: 2021-12-30
    • Source: Internet
    • Author: User
    Tags

    santyl side effects

    iodine health benefits
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com